Intervention
PET/CT scan
ClinicalTrials.gov intervention label
Advertisement
Clinical trials
11 shownPET-imaging of Two Vartumabs in Patients With Solid TumorsNCT06645808 · 2024-12-10
RECRUITINGA Study of Imaging in Demyelinating DiseasesNCT05805839 · 2023-07-10
ENROLLING_BY_INVITATIONProstate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerNCT04030338 · 2019-07-19
ACTIVE_NOT_RECRUITING18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic CancerNCT03790423 · 2019-01-03
COMPLETEDEvaluation of Splenic Metabolic Activity With 18FDG-PET in HypertensionNCT02572765 · 2018-01-02
UNKNOWNT-Cell PET Imaging With [18F]F-AraG in Lung CancerNCT03311672 · 2017-11-26
WITHDRAWNCan HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?NCT02286843 · 2014-11-06
COMPLETED18F FLT Imaging Studies of Treatment Response for Lung Cancer and ThymomaNCT01610544 · 2012-05-10
WITHDRAWNPositron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility StudyNCT00686465 · 2009-03-01
COMPLETEDThe Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung CancerNCT00380666 · 2007-06-01
WITHDRAWNThe Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment PlanningNCT00588328 · 2000-03-01
COMPLETEDCommon conditions
Breast Cancer3Non-small Cell Lung Cancer3Lung Cancer2Ovarian Cancer2Bladder Carcinoma1Breast Cancer Metastases1Carcinoma, Non-Small-Cell Lung1Cervix Cancer1Chondrosarcoma1Colon Carcinoma1Esophageal Cancer1Esophageal Carcinoma1Gastric Carcinoma1Glioblastoma1Head and Neck Cancer1Head and Neck Squamous Cell Carcinoma1HER2 Positive Breast1Hypertension1Inflammatory Demyelinating Disease1Lung Carcinoma1Lymphoma1Metastatic Prostate Cancer1Multiple Sclerosis1Non-Hodgkin's Lymphoma1Osteosarcoma1
Leading sponsors
Trial status mix
COMPLETED4
WITHDRAWN3
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
RECRUITING1
UNKNOWN1
Phase mix
NA3
PHASE23
PHASE12
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.